Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Sause A"'
Autor:
Tim Eisen, David Fisher, Jeffrey Crawford, Stefan Michiels, Caroline Domerg, Cécile Le Péchoux, Mahesh K. B. Parmar, Samithra S.J. Mandrekar, Jayne F. Tierney, Laurence Collette, Audrey Mauguen, Jean Pierre Pignon, Chandra P. Belani, Steven E. Schild, Rebecca Paulus, Suzanne E. Dahlberg, William T. Sause, Frances A. Shepherd, Mary O'Brien, Sarah Burdett, Herbert Pang
Publikováno v:
lancet oncology, 14(7), 619-626. Lancet Publishing Group
Lancet oncology, 14 (7
The Lancet Oncology
Lancet oncology, 14 (7
The Lancet Oncology
Background: The gold standard endpoint in clinical trials of chemotherapy and radiotherapy for lung cancer is overall survival. Although reliable and simple to measure, this endpoint takes years to observe. Surrogate endpoints that would enable earli
Autor:
Cécile Le Péchoux, Stanley Dische, James A. Bonner, Chandra P. Belani, A. Zajusz, Suzanne E. Dahlberg, Sumithra J. Mandrekar, Rebecca Paulus, Rainer Koch, Steven E. Schild, Matthew Nankivell, Michael Baumann, David Ball, Dirk De Ruysscher, Audrey Mauguen, Jean Pierre Pignon, Rodrigo Arriagada, William T. Sause, Michele I. Saunders, Katarzyna Behrendt, Andrew T. Turrisi, James F. Bishop
Publikováno v:
Journal of Clinical Oncology, 30(22), 2788-2797. American Society of Clinical Oncology
Purpose In lung cancer, randomized trials assessing hyperfractionated or accelerated radiotherapy seem to yield conflicting results regarding the effects on overall (OS) or progression-free survival (PFS). The Meta-Analysis of Radiotherapy in Lung Ca
Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung Carcinoma
Autor:
Mitchell Machtay, Ritsuko Komaki, Jennifer Moughan, Kathy S. Albain, Hak Choy, Jeffrey D. Bradley, Walter J. Curran, Rebecca Paulus, Benjamin Movsas, William T. Sause
Publikováno v:
Journal of Thoracic Oncology. 7:716-722
Introduction Local-regional control (LRC) rates for non-small cell lung cancer after chemoradiotherapy were studied (using two different definitions of LRC) for the association between LRC and survival. Methods Seven legacy Radiation Therapy Ooncolog
Autor:
Patricia Lindsay, E. Huang, Joseph O. Deasy, Walter Bosch, Mary V. Graham, William T. Sause, John W. Matthews, Jeffrey D. Bradley, Andrew Hope, Issam El Naqa
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 82:1674-1679
To construct a maximally predictive model of the risk of severe acute esophagitis (AE) for patients who receive definitive radiation therapy (RT) for non-small-cell lung cancer.The dataset includes Washington University and RTOG 93-11 clinical trial
Autor:
Mitchell Machtay, Walter J. Curran, Kathy S. Albain, Ritsuko Komaki, William T. Sause, Kyounghwa Bae, Elizabeth Gore, Benjamin Movsas, Rebecca Paulus
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 82:425-434
Patients treated with chemoradiotherapy for locally advanced non-small-cell lung carcinoma (LA-NSCLC) were analyzed for local-regional failure (LRF) and overall survival (OS) with respect to radiotherapy dose intensity.This study combined data from s
Autor:
Teresa Robertson, Karen Conner, Denitza P. Blagev, Patricia Kruger, Braden Rowley, William T. Sause, Andrew T. Miller, John C. Ruckdeschel
Publikováno v:
Journal of the American College of Radiology : JACR. 13(6)
Purpose Lung cancer screening with low-dose CT (LDCT) demonstrated reduced mortality in the National Lung Screening Trial, yet there is debate as to whether the reported efficacy can translate into comparable effectiveness with community-based screen
Autor:
Walter Bosch, Mary V. Graham, John W. Matthews, Joseph O. Deasy, A. Hope, Jeffrey D. Bradley, Aditya Apte, P. Lindsay, Issam El Naqa, William T. Sause
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 69:985-992
Purpose To test the Washington University (WU) patient dataset, analysis of which suggested that superior-to-inferior tumor position, maximum dose, and D35 (minimum dose to the hottest 35% of the lung volume) were valuable to predict radiation pneumo
Autor:
Mark A. Socinski, David H. Harpole, John J. Welch, Richard Pazdur, Shakun Malik, William T. Sause, Edward L. Korn, Fred R. Hirsch, Claudio Dansky Ullmann, Jeffrey S. Abrams
Publikováno v:
Journal of Thoracic Oncology
On February 2, 2012, the National Cancer Institute (NCI) sponsored a 2-day workshop with the NCI Thoracic Malignancies Steering Committee and the Food and Drug Administration to bring together leading academicians, clinicians, industry and government
Autor:
John R. Strawn, William Sause, Andrew T. Turrisi, David G. Pfister, Mark R. Somerfield, Jemi Olak, Thomas J. Smith, Diane Stover, Christopher G. Azzoli, David H. Johnson, Sherman Baker
Publikováno v:
Journal of Clinical Oncology. 22:330-353
The American Society of Clinical Oncology (ASCO) previously published evidencebased guidelines for the treatment of unresectable non–small-cell lung cancer (NSCLC) [1]. ASCO guidelines are updated periodically by the responsible Expert Panel (Appen
Publikováno v:
Chest. 123:221S-225S
Stage IIIB includes patients with T4, any N, M0, and any T, N3, M0. Surgery may be indicated only for carefully selected T4N0M0 patients with or without neoadjuvant chemotherapy or chemoradiotherapy. Patients with N3 lymph node involvement are not co